Laboratory Products
Nanoparticle-Reduced Sucrose for Biopharmaceutical Formulations
Nov 04 2019
Merck developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with reduced levels of nanoparticle impurities (NPI). The new product, Sucrose EMPROVE® EXPERT Ph Eur, ChP, JP, NF, is the ideal choice for the high-risk applications of manufacturing and formulating biomolecules.
As a widely used protein stabiliser for biomolecule formulation, the quality of sucrose is crucial. In an exclusive collaboration with Coriolis Pharma, Merck designed the new purification process and associated nanoparticle analytics of sucrose. The result is a highly pure sucrose that offers the following benefits over non-purified sucrose: a low level of NPIs on the limit of detection of current technologies, reducing the risk for protein instability; less interference with analytical methods; high batch-to-batch consistency; reduced risk of API damage.
Sucrose EMPROVE® EXPERT Ph Eur, ChP, JP, NF is part of Merck’s broad portfolio of protein stabilising excipients including trehalose, mannitol, sorbitol and glycine. The new offering is part of the company’s Emprove® Program, which facilitates drug product manufacturers’ risk assessment workflows and supplier qualification.
More information online: https://ilmt.co/PL/ODOy
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria